Hot Blue Chip Stocks To Watch Right Now


When it comes to selecting dividend stocks to buy, investors can take their pick: high yield stocks, blue chip stocks with safe payouts, stocks with high dividend growth rates, value stocks; the list goes on.

But selecting undervalued dividend stocks is particularly advantageous for a variety of reasons, not the least of which is that dividend yield is higher when a stock’s price is lower, as they move inversely.

Here are 3 undervalued dividend stocks to buy for high total returns:

Triton International (NYSE:TRTN) Perrigo Company (NYSE:PRGO) LyondellBasell Industries (NYSE:LYB)

A low valuation also means a better chance for higher capital appreciation (in addition to the income received) when that undervalued stock sees its valuation multiples rise.

Dividend Stocks to Buy: Triton International (TRTN) Source: VladSV / Shutterstock.com


Our first stock is Triton International, a company that acquires, leases and sells intermodal containers and chassis to shipping lines, manufacturers and freight forwarders. Triton leases many types of containers including tanks, specialty, dry and refrigerated. It also trades in containers, buying and selling on the open market.

Hot Blue Chip Stocks To Watch Right Now: Standex International Corporation(SXI)

Standex International Corporation was incorporated in 1975 and is the successor of a corporation organized in 1955. As used in this report, the terms “we,” “us,” “our,” the “Company” and “Standex” mean Standex International Corporation and its subsidiaries. We have paid dividends each quarter since Standex became a public corporation in November 1964.
Unless otherwise noted, references to years are to fiscal years.
We are a leading manufacturer of a variety of products and services for diverse commercial and industrial markets. We have 11 operating segments, aggregated and organized for reporting purposes into five segments: Food Service Equipment, Engraving, Engineering Technologies, Electronics and Hydraulics. Overall management, strategic development and financial control are maintained by the executive staff from our corporate headquarters located in Salem, New Hampshire.   Advisors’ Opinion:

  • [By Ethan Ryder]

    Standex Int’l Corp. (NYSE:SXI) – Equities researchers at William Blair boosted their Q3 2019 earnings per share (EPS) estimates for shares of Standex Int’l in a note issued to investors on Monday, October 1st. William Blair analyst N. Heymann now expects that the industrial products company will earn $1.51 per share for the quarter, up from their prior estimate of $1.49.

  • [By Stephan Byrd]

    Standex Int’l Corp. (NYSE:SXI) has been assigned a consensus rating of “Hold” from the eight brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $120.50.

Hot Blue Chip Stocks To Watch Right Now: AMAG Pharmaceuticals, Inc.(AMAG)


AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company, provides products and services with a focus on maternal health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company also offers Cord Blood Registry services that are related to the collection, processing, and storage of umbilical cord blood and cord tissue units. In addition, it has a license agreement with Velo to acquire the rights to digoxin immune fab, a polyclonal antibody in clinical development for the treatment of severe preeclampsia in pregnant women. The company sells Feraheme to authorized wholesalers and specialty distributors. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.


Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on First Mid-Illinois Bancshares (FMBH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of First Mid-Illinois Bancshares, Inc. (NASDAQ:FMBH) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $44.25.

Hot Blue Chip Stocks To Watch Right Now: Greenhill & Co., Inc.(GHL)


Greenhill & Co., Inc., together with its subsidiaries, operates as an independent investment bank for corporations, partnerships, institutions, and governments worldwide. The company provides financial advisory services primarily related to mergers and acquisitions, restructurings, financings, and capital raisings. It is involved in the provision of advisory services to clients in relation to domestic and cross-border mergers, acquisitions, divestitures, spin-offs, and other strategic transactions, as well as various stages of these transactions, from initial structuring to final execution. The company also advises clients on strategic matters, such as activist response, defensive tactics, special committee projects, licensing deals, joint ventures, valuation, negotiation tactics, industry dynamics, structuring alternatives, and timing and pricing of transactions, as well as financing alternatives. In addition, it engages in advising debtors, creditors, governments, pension funds, and other stakeholders in companies experiencing financial distress, as well as potential acquirers of distressed companies and assets. Further, the company assists the clients, who seek court-assisted reorganizations by developing and seeking approval for plans of reorganization, as well as in the implementation of such plans. It also assists general partners, fund managers, and sponsors in raising capital for new funds; and provides related advisory services to pension funds, sovereign wealth funds, endowments, and other institutional investors, as well as on secondary market transactions. The company was founded in 1996 and is headquartered in New York, New York.


Leave a Reply

Your email address will not be published.